When almost all the sectoral indices have supported the benchmark indices in its marginal upswing, the Nifty Pharma index, continued to fall shedding more than 0.5 per cent. Recently, it has bounced back from 50 per cent retracement of an upward rally from double bottom. However, we can expect fresh buying in the index only above 9,100 levels.

Real estate major Lodha Developers is buckling up to file its draft prospectus with SEBI to launch its IPO soon, according to reports. The initial public offering is expected to be one of the most notable debuts in the Indian stock this year. 

The PAT for the quarter came in at Rs. 12.77 crore, yoy decline of 23.5 per cent. This was due to sharp jump in interest expenses by 72.8 per cent yoy.

As part of a global alliance, Nestle strikes a deal to market Starbucks' coffee products outside the Starbucks cafes, internationally.

The company posted subdued performance for Q4FY18, with decline in revenue for the quarter and also decline in profits

Overall volumes in futures & options currently stand at 42.75 crore contracts with a turnover of Rs. 3,67,606.45 crore.

Overall volumes in futures & options currently stand at 42.75 crore contracts with a turnover of Rs. 3,67,606.45 crore.

In the coming session, a decisive move below Friday’s session low of 10,601.60 could open gates for the level of 10,560, followed by 10,500 while, on the upside, immediate resistance is seen at 10,650, followed 10,680. Stocks in the news: Larsen and Toubro, Bodal Chemicals, Smartlink Holdings, Infosys, PC Jeweller, Cadila Healthcare, Fortis Healthcare and Glenmark Pharmaceuticals. 

Indian benchmark indices are likely to make a mildly positive start. The SGX Nifty is indicating that Nifty may open marginally higher by 19 points at 10,686.   

If you think that all equity mutual funds are the same and one equity fund is no different from the other, think again! There is a wide spectrum of equity mutual funds that cater to different categories of investors having different kinds of financial goals, return expectations and risk appetites.